| 2022-08-12 |
复牌提示：
2022-08-11 19:49:42 停牌，复牌日期 2022-08-15 00:00:01
|
| 2022-08-12 |
详情>>
内部人交易：
BEVERIDGE, ROY A等共交易23笔
|
| 2022-08-09 |
详情>>
股本变动：
变动后总股本16836.48万股
|
| 2022-08-09 |
详情>>
业绩披露：
2022年中报每股收益-0.59美元,归母净利润-9124.9万美元,同比去年增长32.23%
|
| 2022-05-10 |
详情>>
业绩披露：
2022年一季报每股收益-0.38美元,归母净利润-5550.5万美元,同比去年增长21.02%
|
| 2022-05-10 |
财报披露：
美东时间 2022-05-10 盘前发布财报
|
| 2022-03-30 |
股东大会：
将于2022-05-17召开股东大会
会议内容 ▼▲
- 1.Election of four class III directors to our board of directors, each to serve until the 2025 annual meeting of stockholders;
2.Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
3.Approval on an advisory (non-binding) basis, of the compensation of our named executive officers;
4.Approval of an amendment to our Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 225,000,000 to 450,000,000;
5.Approval of the Epizyme, Inc. 2022 Equity Incentive Plan;
6.Approval of an amendment to the Epizyme, Inc. 2013 Employee Stock Purchase Plan to eliminate the annual “evergreen” provision and authorize 2,500,000 shares of common stock for issuance under such plan;
7.Transaction of any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2022-03-01 |
详情>>
业绩披露：
2019年年报每股收益-1.93美元,归母净利润-1.73亿美元,同比去年增长-40.12%
|
| 2022-03-01 |
详情>>
业绩披露：
2021年年报每股收益-2.45美元,归母净利润-2.51亿美元,同比去年增长-8.39%
|
| 2021-11-09 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-1.96美元,归母净利润-2亿美元,同比去年增长-21.16%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-09 |
详情>>
业绩披露：
2021年中报每股收益-1.32美元,归母净利润-1.35亿美元,同比去年增长-23.08%
|
| 2021-05-06 |
详情>>
业绩披露：
2020年一季报每股收益-0.51美元,归母净利润-5093.7万美元,同比去年增长-57.8%
|
| 2021-05-06 |
详情>>
业绩披露：
2021年一季报每股收益-0.69美元,归母净利润-7027.4万美元,同比去年增长-37.96%
|
| 2021-04-29 |
股东大会：
将于2021-06-11召开股东大会
会议内容 ▼▲
- 1.Election of three class II directors to our board of directors, each to serve until the 2024 annual meeting of stockholders;
2.Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021;
3.Approval on an advisory (non-binding) basis, of the compensation of our named executive officers;
4.Approval of an amendment to our Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 150,000,000 to 225,000,000;
5.Transaction of any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2021-02-23 |
详情>>
业绩披露：
2020年年报每股收益-2.29美元,归母净利润-2.32亿美元,同比去年增长-33.75%
|
| 2020-11-06 |
详情>>
业绩披露：
2020年三季报(累计)每股收益-1.64美元,归母净利润-1.65亿美元,同比去年增长-41.62%
|
| 2020-08-04 |
详情>>
业绩披露：
2020年中报每股收益-1.09美元,归母净利润-1.09亿美元,同比去年增长-35.48%
|
| 2020-04-17 |
股东大会：
将于2020-05-29召开股东大会
会议内容 ▼▲
- 1.Election of four class I directors to our board of directors, each to serve until the 2023 annual meeting of stockholders;
2.Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020;
3.Approval on an advisory (non-binding) basis, of the compensation of our named executive officers;
4.Approval of an amendment to our Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 125,000,000 to 150,000,000;
5.Transaction of any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2019-04-18 |
股东大会：
将于2019-05-31召开股东大会
会议内容 ▼▲
- 1.Election of three class III directors to our board of directors, each to serve until the 2022 annual meeting of stockholders;
2.Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019;
3.Approval on an advisory (non-binding) basis, of the compensation of our named executive officers;
4.Holding, on an advisory (non-binding) basis, an annual vote on the compensation of our named executive officers;
5.Transaction of any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2018-04-05 |
股东大会：
将于2018-05-18召开股东大会
会议内容 ▼▲
- 1.Election of three class II directors to our board of directors, each to serve until the 2021 annual meeting of stockholders;
2.Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018;
3.Transaction of any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2017-04-28 |
股东大会：
将于2017-06-22召开股东大会
会议内容 ▼▲
- 1. Election of three class I directors to our board of directors, each to serve until the 2020 annual meeting of stockholders;
2. Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017;
3. Transaction of any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2016-04-15 |
股东大会：
将于2016-05-19召开股东大会
会议内容 ▼▲
- 1.Election of two class III directors to our board of directors, each to serve until the 2019 annual meeting of stockholders;
2.Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2016;
3.Transaction of any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2015-04-15 |
股东大会：
将于2015-05-19召开股东大会
会议内容 ▼▲
- 1.Election of two class II directors to the company's board of directors, each to serve until the 2018 annual meeting of stockholders;
2.Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2015;
3.Transaction of any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2014-04-30 |
股东大会：
将于2014-06-09召开股东大会
会议内容 ▼▲
- 1. Election of one class I director to our board of directors, to serve until the 2017 annual meeting of stockholders;
2. Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2014;
3. Transaction of any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|